These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 968178)

  • 1. Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.
    Meffin PF; Harapat SR; Harrison DC
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):31-51. PubMed ID: 968178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
    Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
    N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of acebutolol-d6 in the rat correlates with the identification of a new metabolite in human urine.
    Andresen BD; Davis FT
    Drug Metab Dispos; 1979; 7(6):360-5. PubMed ID: 43220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of acebutolol].
    Collins RF
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3223-8. PubMed ID: 768905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.
    Meffin PJ; Harapat SR; Yee YG; Harrison DC
    J Chromatogr; 1977 Aug; 138(1):183-91. PubMed ID: 893593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acebutolol metabolite plasma concentration during chronic oral therapy.
    Winkle RA; Meffin PJ; Ricks WB; Harrison DC
    Br J Clin Pharmacol; 1977 Oct; 4(5):519-22. PubMed ID: 911602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
    Sankey MG; Gulaid A; Kaye CM
    J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thin-layer chromatographic method for the determination of acebutolol and its major metabolite in serum.
    Steyn JM
    J Chromatogr; 1976 May; 120(2):465-72. PubMed ID: 5463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.
    Jiang H; Randlett C; Junga H; Jiang X; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):173-80. PubMed ID: 19109073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent acebutolol disposition after oral administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1978 Nov; 24(5):542-7. PubMed ID: 699478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of grapefruit juice on the pharmacokinetics of acebutolol.
    Lilja JJ; Raaska K; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):659-63. PubMed ID: 16305592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acebutolol disposition after intravenous administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.
    Simons KJ; Levy RH; Cutler RE; Christopher GT; Lindner A
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):173-85. PubMed ID: 1153866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spectrofluorometric determination of a new beta-blocking agent, acebutolol in blood and urine].
    Roux A; Flouvat B; Delaveau P
    Ann Biol Clin (Paris); 1975; 33(4):281-8. PubMed ID: 2088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecific high-performance liquid chromatographic assay of acebutolol in human plasma and urine.
    Piquette-Miller M; Foster RT; Pasutto FM; Jamali F
    J Chromatogr; 1990 Mar; 526(1):129-37. PubMed ID: 2341525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the antidepressant levoprotiline and its N-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry.
    Ackermann R; Kaiser G; Schueller F; Dieterle W
    Biol Mass Spectrom; 1991 Nov; 20(11):709-16. PubMed ID: 1799582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous plasma levels determination of mexiletine and one of its metabolites by electron capture gas-liquid chromatography.
    Pachecus A; Santoni Y; Fornaris M; Magnan S; Aubert C; Ragon A; Cano JP
    Arzneimittelforschung; 1982; 32(6):688-93. PubMed ID: 6889428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man.
    Gabriel R; Kaye CM; Sankey MG
    J Pharm Pharmacol; 1981 Jun; 33(6):386-7. PubMed ID: 6115014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.